Acquisition in China: Reed Sinopharm invests ...
Acquisition in China

Reed Sinopharm invests in CHCC

Photo: Scott Graham on Unsplash

Reed Sinopharm Exhibitions, the joint venture between Reed Exhibitions and the Sinopharm Group, has signed a definitive agreement to acquire a majority stake in the China Hospital Construction Conference (CHCC). CHCC is Asia's leading event in comprehensive and innovative solutions for hospital design, building and management. Launched in 1999, the event spans over 100,000 sqm, featuring over 600 exhibitors and 16 themed displays. In addition to the trade show exhibition, CHCC also produces over 80 conference sessions and offers excellent learning opportunities, knowledge sharing and information exchange for over 10,000 hospital designers and managers every year.

Commenting on the acquisition, Hugh Jones, CEO of Reed Exhibitions, said: "We have been very impressed by the CHCC team's continuous drive to innovate and build a broad platform for the coordinated development of the whole industry. I firmly believe that in adding the CHCC brand to Reed Sinopharm Exhibitions' health sector portfolio, we will bring our expertise in face-to-face and virtual experiences, global reach and resources, to bear on CHCC's members, stakeholders, academics and industry leaders, ensuring growth, development and value for all our partners".
„We drive to innovate and build a broad platform for the coordinated development of the whole industry.“
Hugh Jones, CEO of Reed Exhibitions
The 22nd CHCC is scheduled to take place at Shenzhen World Exhibition & Convention Center from June 19 to 21, 2021. Thousands of hospital construction decision-makers and more than 800 outstanding enterprises will gather together to discuss the construction of the next generation hospitals.

www.reedexhibitions.com/reed-sinopharm-exhibitions-acquires-majority-stake-china-hospital-construction-conference
stats